| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 10/11/2006 | CN1845683A Composition and method for facilitating bone healing |
| 10/11/2006 | CN1843508A A composition for treating gastrointestinal distress |
| 10/11/2006 | CN1279014C Vitamin A analogue derivative with antiangiogenic, antitumoral and proapoptotic activities |
| 10/11/2006 | CN1278690C 25-hydroxy vitamin D3 compositions |
| 10/11/2006 | CN1278683C Use of dipeptidyl peptidase IV inhibitor in preparing medicine for treating anxiety neurosis |
| 10/11/2006 | CN1278681C Adduct of topiramate and tramadol hydrochloride and uses thereof |
| 10/10/2006 | US7119165 Nogo receptor-mediated blockade of axonal growth |
| 10/10/2006 | US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders |
| 10/10/2006 | US7119112 Sulfonamides as potassium channel blockers |
| 10/10/2006 | US7119110 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 10/10/2006 | US7119096 Anticancer agents |
| 10/10/2006 | US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates |
| 10/10/2006 | US7119075 a microbiocide and a bioenhancer; 4-((1,3-benzodioxol-6-yl)-1,3-butadien-1-yl)-N-carbonylpiperidine and 3',5-Dihydroxy flavone 7-O- beta -D-galacturonide-4'-O- beta -D-glucopyranoside; reduced antibiotic resistance |
| 10/10/2006 | US7118902 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis |
| 10/10/2006 | US7118873 Polynucleotides encoding cellular transporters and methods of use thereof |
| 10/10/2006 | US7118746 Conditioned cell culture medium compositions and methods of use |
| 10/10/2006 | US7118742 Ligand for herpes simplex virus entry mediator and methods of use |
| 10/10/2006 | CA2291233C Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 10/05/2006 | WO2006104289A1 Pharmaceutical composition for inhibition of tumor growth |
| 10/05/2006 | WO2006104136A1 Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease |
| 10/05/2006 | WO2006104099A1 RORα PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 10/05/2006 | WO2006104008A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/05/2006 | WO2006102804A1 The compound preparation for treating diabetes mellitus |
| 10/05/2006 | WO2006055747A3 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 10/05/2006 | WO2005112983A3 Modulation of immunoglobulin production and atopic disorders |
| 10/05/2006 | WO2005080338A8 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins |
| 10/05/2006 | WO2005070081A3 Methods of using zonisamide as an adjunctive therapy for partial seizures |
| 10/05/2006 | US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 10/05/2006 | US20060223870 Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
| 10/05/2006 | US20060223869 Dopamine D1, D2, D3, and D4 receptor agonist such as pramipexole in combination with a second active substance selected from D1, D2, D3, and D4 receptor agonists, anorectics, lipase inhibitors and sympathomimetics; for treating overweight or obesity or type 2 diabetes |
| 10/05/2006 | US20060223857 Combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
| 10/05/2006 | US20060223832 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/05/2006 | US20060223815 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 10/05/2006 | US20060223793 Use of dopamine d3 receptor ligands for the production of drugs for treating renal function disorders |
| 10/05/2006 | US20060223790 Modulation of Microglial by Nicotinic Medications |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223779 Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4 |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | US20060223180 Methods to mobilize progenitor/stem cells |
| 10/05/2006 | US20060223158 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 10/05/2006 | US20060223119 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 10/05/2006 | US20060223082 Map |
| 10/05/2006 | US20060222756 Medical devices, drug coatings and methods of maintaining the drug coatings thereon |
| 10/05/2006 | US20060222714 Agent for preventing and ameliorating constipation |
| 10/05/2006 | US20060222691 Composition for the transdermal delivery of fentanyl |
| 10/05/2006 | US20060222689 vitamin C, vitamin B complex, carotene, vitamin E, a fragrance, a thickener and a surfactant; acne treamtent |
| 10/05/2006 | US20060222641 Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism |
| 10/05/2006 | US20060222628 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses |
| 10/05/2006 | CA2603433A1 Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist |
| 10/05/2006 | CA2602716A1 Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease |
| 10/05/2006 | CA2602351A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/04/2006 | EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/04/2006 | EP1707216A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 10/04/2006 | EP1707215A1 Remedy for angitis |
| 10/04/2006 | EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity |
| 10/04/2006 | EP1707205A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 10/04/2006 | EP1707193A2 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases |
| 10/04/2006 | EP1707189A2 Use of a vegetable oil product as agent for increasing skin lipid synthesis |
| 10/04/2006 | EP1706375A2 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
| 10/04/2006 | EP1706147A2 COMBINATION THERAPY WITH 5-HT sb 1A /sb AND 5-HT sb 1B /sb RECEPTOR ANTAGONISTS |
| 10/04/2006 | EP1706146A1 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 10/04/2006 | EP1706126A2 Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria |
| 10/04/2006 | EP1706122A2 Anti-viral pharmaceutical compositions |
| 10/04/2006 | EP1706115A1 Controlled release pharmaceutical composition comprising an acid-insoluble and a bioadhesive polymer |
| 10/04/2006 | EP1706107A1 Synergistic neuroprotective combinations of flavanols, hydroxystilbenes, flavanones, flavones, flavonols, proanthocyanidins and anthocyanidins |
| 10/04/2006 | EP1626724A4 Method and kit for regulation of microvascular tone |
| 10/04/2006 | EP1531792A4 Abuse-resistant opioid dosage form |
| 10/04/2006 | EP1513840B1 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 10/04/2006 | EP1507527A4 Methods for enhancing motor performance and/or endurance |
| 10/04/2006 | EP1487831B1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs |
| 10/04/2006 | EP1455603B1 Stimulation of in vivo production of proteins with formulation comprising leucine |
| 10/04/2006 | EP1420799B1 Use of atazanavir in hiv therapy |
| 10/04/2006 | EP1395128B1 Acid controlled viscosity fibre system and uses thereof |
| 10/04/2006 | EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 10/04/2006 | EP1354602B1 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 10/04/2006 | EP1349541B1 Self emulsifying lipid matrix (selm) |
| 10/04/2006 | EP1341520B1 Antibiotic/benzoyl peroxide dispenser |
| 10/04/2006 | EP1341515B1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same |
| 10/04/2006 | EP1311691B1 Method and compositions for promoting osteogenesis |
| 10/04/2006 | EP1255827B1 Oligonucleotides and their use for modulating the expression of tyrosinase involved in the synthesis of melanic pigments |
| 10/04/2006 | EP1253945B1 Ace inhibitor-vasopressin antagonist combinations |
| 10/04/2006 | EP1206942B1 Water channel opener compositions and medicinal compositions for ophthalmic use |
| 10/04/2006 | EP1202746B1 Nsaid and egfr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 10/04/2006 | EP1143931B1 Pulmonary drug delivery |
| 10/04/2006 | EP1135513B1 Adenovirus-mediated gene therapy |
| 10/04/2006 | EP1119361A4 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
| 10/04/2006 | EP1027047B1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 10/04/2006 | EP0957936B1 Formulations of recombinant papillomavirus vaccines |
| 10/04/2006 | CN1842341A Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng |
| 10/04/2006 | CN1842326A Suppressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 10/04/2006 | CN1842277A Infant formula |
| 10/04/2006 | CN1842276A 增补制剂 Added preparations |
| 10/04/2006 | CN1841066A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 10/04/2006 | CN1840195A A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 10/04/2006 | CN1840194A Injection liquid of human autogenous collagen living cell and preparation method thereof |
| 10/04/2006 | CN1840193A Nanometer capsule of anthracene nucleus anticancer antibiotic with polyethylene glycol-phospholipid |
| 10/04/2006 | CN1840181A Therapeutic use of selective PDE10 inhibitors |
| 10/04/2006 | CN1839873A Pharmaceutically active uridine esters |
| 10/04/2006 | CN1839843A Fluorouracil slow release injection |
| 10/04/2006 | CN1839833A Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |